Cancer treatment could face landmark moment with promising vaccine
The drug, intismeran autogene, treats melanoma, the deadliest form of skin cancer, of which the US National Cancer…
Rejuvenate Bio secures funding and Merck partnership
New funds and strategic collaboration with Merck Animal Health will support development of therapies targeting age-related diseases in…
Mizuho Strategist: Healthcare Is Now a Value Sector as Pharma Stocks Underperform Tech
Quick Read Merck’s Keytruda posted $8 billion in Q1 sales, while Summit’s ivonescimab faces binary risk ahead of…
Global drug makers face pricing pressure as China targets affordable healthcare
Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
Merck’s Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy?
Merck shares began peeling back in early 2024, mostly on concerns about looming patent expirations for its breadwinning…
Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as…